Quantum-Testing Infrastructure for Quantum Technologies
Expected Outcome: This action will establish a pan-European open-access testing and experimentation infrastructure for quantum technologies, enabling systematic validation and certification of quantum components and systems. Expected outcomes include: Deployment of distributed quantum testing facilities accessible across Europe, including remote access and standardized test protocols. Provision of
The official English text of the call comes from the European Commission's Funding & Tenders portal.
Deadline
17 November 2026 24 days left
Grant per project
19–20 million EURTotal budget: 20 million EUR · about 1 funded projects
Region
International (EU)
Grant writers send you a quote — free, and with no obligation.1 expert takes on calls like this →
Eligibility criteria
EU direct call: eligibility depends mainly on the consortium, the participants' countries and their types of organisation. We cannot check these from your company details, so we do not tell you whether you are eligible. The criteria are in the official call.
Official callQuestions about this call?
Your assistant answers from the call's text and writes a working draft from your project idea.
What is this call about?
Official description
Expected outcome and scope
Expected Outcome: This action will establish a pan-European open-access testing and experimentation infrastructure for quantum technologies, enabling systematic validation and certification of quantum components and systems. Expected outcomes include: Deployment of distributed quantum testing facilities accessible across Europe, including remote access and standardized test protocols. Provision of certification services aligned with future standardisation efforts, ensuring trust, quality, and interoperability of quantum technologies. Support for SMEs, start-ups, and research institutions in validating quantum components and sub-systems.
Strengthening of Europe’s competitiveness by ensuring robust quality assurance mechanisms and accelerating the time-to-market of emerging quantum products. Scope: The proposal should implement the testing-related part of the action plan established under the Framework Partnership Agreement for Qu-Test. The action must include: Expansion and interconnection of open-access testing facilities in multiple Member States, covering a range of quantum technologies (e.g., processors, sensors, photonics, control systems). Development and deployment of interoperable testing methodologies, benchmarking protocols, and certification procedures. Integration of metrological and validation capabilities into existing RTOs and academic infrastructures, focusing on TRL 4–7. Creation of a comprehensive digital platform supporting users in test planning, remote execution, and data reporting. Engagement with industry, especially start-ups and SMEs, to define user-driven requirements and access models. Establishment of feedback loops between testing and design/manufacturing entities to inform improvements and accelerate iterative development. Coordination with relevant European and international standardisation initiatives to prepare the ground for widespread adoption of certified quantum components. Alignment with SRIA 2030 objectives, focusing on ecosystem-wide support for quality, reliability, and reproducibility in quantum technology development. Technology Readiness Level - Technology readiness level expected from completed projects The rules are described in General Annex B of the Horizon Europe Work Programme 2026-2027. Testing activities (no TRL applies) are expected to validate technologies starting at TRL 3/4 and confirm their progression to TRL 5/7 by the end of the project.
Eligibility and submission conditions
"> General conditions 1. Admissibility conditions: Proposal page limit and layout described in Annex A and Annex E of the Horizon Europe Work Programme General Annexes. Proposal page limits and layout: described in Part B of the Application Form available in the Submission System. 2. Eligible countries described in Annex B of the Work Programme General Annexes. The following exceptions apply: the eligibility conditions are those established in the EuroHPC JU Council Regulation (EU) 2021/1173 as last amended by Council Regulation 2026/150. In accordance with Article 22.5 of the HE Regulation, the Governing Board has decided that in order to achieve the expected outcomes, and safeguard the Union’s strategic assets, interests, autonomy, or security participation is limited to legal entities established in Member States or Participating States of the EuroHPC JU At the moment of the adoption of the Amendment No 5, the Participating States of EuroHPC JU are Albania, Austria, Belgium, Bulgaria, Croatia, Cyprus, Czechia, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Israel, Italy, Latvia, Lithuania, Luxembourg, Malta, Moldova, Montenegro, Netherlands, North Macedonia, Norway, Poland, Portugal, Romania, Serbia, Slovakia, Slovenia, Spain, Sweden, Switzerland, Türkiye and United Kingdom ( [Discover EuroHPC JU - The European High Performance Computing Joint Undertaking (EuroHPC JU) ) ]. In addition, legal entities which are established in associated countries to Horizon Europe that become a participant state to EuroHPC JU before the signature of the grant agreement will also become eligible. For the duly justified and exceptional reasons listed in the paragraph above, in order to guarantee the protection of the strategic interests of the Union and its Member States, entities established in an eligible country listed above, but which are directly or indirectly controlled by a non-eligible country or by a non-eligible country entity, may not participate in the action unless it can be demonstrated, by means of guarantees approved by the eligible country of establishment, that their participation to the action would not negatively impact the Union’s strategic, assets, interests, autonomy, or security. 3. Other Eligibility Conditions described in Annex B of the Work Programme General Annexes. 4. Financial and operational capacity and exclusion described in Annex C of the Work Programme General Annexes. 5a. Evaluation and award: Award criteria, scoring and thresholds described in Annex D of the Work Programme General Annexes. 5b. Evaluation and award: Submission and evaluation processes The general criteria are described in the General Annex D of the Horizon Europe Work Programme 2026-2027. described in Annex F of the Work Programme General Annexes and the Online Manual . 5c. Evaluation and award: Indicative timeline for evaluation and grant agreement described in Annex F of the Work Programme General Annexes. 6. Legal and financial set-up of the grants described in Annex G of the Work Programme General Annexes. Specific conditions described in the [specific topic of the Work Programme] The documents are described in General Annex E of the Horizon Europe Work Programme 2026-2027. Application and evaluation forms and model grant agreement (MGA): Application form templates Please use the application form that you will find in the Submission System. You can find examples of standard application forms in the Reference Documents page . Evaluation form templates — will be used with the necessary adaptations Standard evaluation form (HE RIA, IA) Standard evaluation form (HE CSA) Standard evaluation form (HE RIA, IA and CSA Stage 1) Standard evaluation form (HE RIA, IA and CSA Stage 1 BLIND) Standard evaluation form (HE PCP PPI) Standard evaluation form (HE COFUND) Standard evaluation form (HE FPA) Standard evaluation form (HE MSCA) Standard evaluation form (HE EIC PATHFINDER CHALLENGES) Standard evaluation form (HE EIC PATHFINDER OPEN) Standard evaluation form (HE EIC TRANSITION) Standard evaluation form (HE EIC Accelerator stage 1 - short proposal) Standard evaluation form (HE EIC Accelerator stage 2 - full proposal) Guidance HE Programme Guide Model Grant Agreements (MGA) HE MGA HE Unit MGA Lump Sum MGA Operating Grants MGA Framework Partnership Agreement FPA Call-specific instructions Detailed budget table (HE LS) Information on financial support to third parties (HE) Information on clinical studies (HE) Guidance: "Lump sums - what do I need to know?" Additional documents: EuroHPC Work Programme 2026 (Decision 22/2026 Amendment No 3) HE Main Work Programme 2026-2027 – 1. General Introduction HE Main Work Programme 2026-2027 – 7. Digital, Industry and Space HE Main Work Programme 2026-2027 – 11. Widening participation and strengthening the European Research Area HE Main Work Programme 2026-2027 – 12. Missions HE Main Work Programme 2026-2027 – 13. New European Bauhaus Facility (NEB) HE Main Work Programme 2026-2027 – 14. Horizontal Activities HE Main Work Programme 2026-2027 – 15. General Annexes HE Framework Programme and Rules for Participation Regulation 2021/695 HE Specific Programme Decision 2021/764 EU Financial Regulation 2024/2509 Decision authorising the use of lump sum contributions under the Horizon Europe Programme Rules for Legal Entity Validation, LEAR Appointment and Financial Capacity Assessment EU Grants AGA — Annotated Model Grant Agreement Funding & Tenders Portal Online Manual Funding & Tenders Portal Terms and Conditions Funding & Tenders Portal Privacy Statement
Hivatkozott dokumentumok
Annex B Annex A Online Manual Standard evaluation form (HE RIA, IA) Standard evaluation form (HE CSA) Standard evaluation form (HE RIA, IA and CSA Stage 1) Standard evaluation form (HE RIA, IA and CSA Stage 1 BLIND) Standard evaluation form (HE PCP PPI) Standard evaluation form (HE COFUND) Standard evaluation form (HE FPA) Standard evaluation form (HE MSCA) Standard evaluation form (HE EIC PATHFINDER CHALLENGES) Standard evaluation form (HE EIC PATHFINDER OPEN) Standard evaluation form (HE EIC TRANSITION) Standard evaluation form (HE EIC Accelerator stage 1 - short proposal) Standard evaluation form (HE EIC Accelerator stage 2 - full proposal) HE Programme Guide HE MGA HE Unit MGA Lump Sum MGA Operating Grants MGA Framework Partnership Agreement FPA Detailed budget table (HE LS) Information on financial support to third parties (HE) Information on clinical studies (HE) Guidance: "Lump sums - what do I need to know?" EuroHPC Work Programme 2026 (Decision 22/2026 Amendment No 3) HE Main Work Programme 2026-2027 – 1. General Introduction HE Main Work Programme 2026-2027 – 7. Digital, Industry and Space HE Main Work Programme 2026-2027 – 11. Widening participation and strengthening the European Research Area HE Main Work Programme 2026-2027 – 12. Missions HE Main Work Programme 2026-2027 – 13. New European Bauhaus Facility (NEB) HE Main Work Programme 2026-2027 – 14. Horizontal Activities Decision authorising the use of lump sum contributions under the Horizon Europe Programme Rules for Legal Entity Validation, LEAR Appointment and Financial Capacity Assessment EU Grants AGA — Annotated Model Grant Agreement Funding & Tenders Portal Terms and Conditions
Grant writers send you a quote — free, and with no obligation.1 expert takes on calls like this →
Related open calls
- EIC Accelerator 2026 - Short proposal4 November 202611 days leftHorizon Europe / EU direct
- Climate security and civil preparedness – new ways to develop pre- and post-crisis climate-change related scenarios for a more resilient Europe5 November 202612 days leftHorizon Europe / EU direct
- Demand-led innovation in security5 November 202612 days leftHorizon Europe / EU direct
- Public procurement of innovation for security5 November 202612 days leftHorizon Europe / EU direct
- Development of ecosystem and next-generation capabilities for a secured European Critical Communication System in civil security5 November 202612 days leftHorizon Europe / EU direct
- Supporting the achievement of the objectives of the Council of Europe Convention on preventing and combating violence against women (VAW) and domestic violence in the Union and the implementation of the Directive on combating VAW and domestic violence5 November 202612 days leftHorizon Europe / EU direct
Deadline · 24 days left
17 November 2026